Does gabapentin cause weight gain
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Weight Gain: An Overview
Introduction to Gabapentin and Its Uses
Gabapentin is a medication primarily used to treat epilepsy and neuropathic pain. It is known for its relatively benign adverse effect profile, with common side effects including dizziness, fatigue, and peripheral edema 48. However, weight gain has also been reported as a potential side effect, raising concerns among patients and healthcare providers.
Incidence of Weight Gain with Gabapentin
Clinical Trials and Observational Studies
Several studies have investigated the relationship between gabapentin and weight gain. In a systematic review and meta-analysis, gabapentin was associated with an average weight gain of 2.2 kg . This finding is supported by a study that reviewed changes in body weight in patients treated with gabapentin for seizure disorders, where a significant number of patients experienced weight gain. Specifically, 10 out of 44 patients gained more than 10% of their baseline weight, and 15 patients gained between 5% to 10% of their baseline weight .
Comparative Studies with Other Medications
In a randomized phase 2 trial comparing gabapentin enacarbil (GEn), a prodrug of gabapentin, with pregabalin and placebo, the incidence of weight gain was lower in patients treated with GEn compared to those treated with pregabalin. The study found that the proportions of patients who experienced a weight gain of 5% or more were 5% (1200 mg), 7% (2400 mg), and 10% (3600 mg) for GEn, compared to 15% for pregabalin and 3% for placebo 12.
Mechanisms and Duration of Weight Gain
Onset and Stabilization
Weight gain associated with gabapentin typically begins between the second and third months of treatment and tends to stabilize after 6 to 9 months, even if the dosage remains unchanged . This pattern suggests that the weight gain may be dose-dependent and could plateau over time.
Long-term Effects
In a long-term study of a gastroretentive formulation of gabapentin (G-GR) in patients with postherpetic neuralgia, the mean weight change from baseline to the end of the study was +0.76 kg, indicating minimal weight gain over an extended period . This suggests that while initial weight gain may occur, it may not continue to increase significantly with prolonged use.
Conclusion
Gabapentin is associated with weight gain in some patients, with the extent of weight gain varying based on dosage and duration of treatment. Comparative studies indicate that gabapentin may cause less weight gain than other medications like pregabalin. While the weight gain tends to stabilize over time, it is important for healthcare providers to monitor patients' weight and consider this side effect when prescribing gabapentin, especially for long-term use. Further research is needed to fully understand the mechanisms behind gabapentin-induced weight gain and to develop strategies to mitigate this side effect.
Sources and full results
Most relevant research papers on this topic